RARECHEM AK ML 0283
CAS21464-51-7
RARECHEM AK ML 0283 (CAS 21464-51-7, C9H12ClNO) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 21464-51-7
- Formula
- C9H12ClNO
- Mol. weight
- 185.65 g/mol
Chemical Specifications
Identifiers
| CAS number | 21464-51-7 |
|---|---|
| Product name | RARECHEM AK ML 0283 |
| Chinese name | 3-氨基-3-(2-氯苯基)-1-丙醇 |
| Synonyms | RARECHEM AK ML 0283; DL-BETA-(2-CHLOROPHENYL)ALANINOL; 3-AMINO-3-(2-CHLORO-PHENYL)-PROPAN-1-OL; DL-3-(2-CHLOROPHENYL)-BETA-ALANINOL; REF DUPL: DL-beta-(2-chlorophenyl)alaninol |
| Molecular formula | C9H12ClNO |
| Molecular weight | 185.65 g/mol |
Physical and chemical properties
| Boiling Point | 152.1 ( ℃ ) |
|---|
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of RARECHEM AK ML 0283?
The CAS Registry Number of RARECHEM AK ML 0283 is 21464-51-7. RARECHEM AK ML 0283 is also known as RARECHEM AK ML 0283; DL-BETA-(2-CHLOROPHENYL)ALANINOL; 3-AMINO-3-(2-CHLORO-PHENYL)-PROPAN-1-OL.
What is the molecular formula and molecular weight of RARECHEM AK ML 0283?
The molecular formula of RARECHEM AK ML 0283 is C9H12ClNO, and its molecular weight is 185.65 g/mol.
How can I request a quotation for RARECHEM AK ML 0283?
Send an inquiry for RARECHEM AK ML 0283 (CAS 21464-51-7) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for RARECHEM AK ML 0283
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.